- Home
- VIVK vs GOVX Comparison
VIVK vs GOVX Comparison
Compare VIVK & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVK
- GOVX
- Stock Information
- Founded
- VIVK 2006
- GOVX 2001
- Country
- VIVK United States
- GOVX United States
- Employees
- VIVK N/A
- GOVX N/A
- Industry
- VIVK Oilfield Services/Equipment
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- VIVK Energy
- GOVX Health Care
- Exchange
- VIVK Nasdaq
- GOVX Nasdaq
- Market Cap
- VIVK 20.9M
- GOVX 16.8M
- IPO Year
- VIVK N/A
- GOVX N/A
- Fundamental
- Price
- VIVK $0.26
- GOVX $0.54
- Analyst Decision
- VIVK
- GOVX Strong Buy
- Analyst Count
- VIVK 0
- GOVX 3
- Target Price
- VIVK N/A
- GOVX $10.67
- AVG Volume (30 Days)
- VIVK 8.0M
- GOVX 1.0M
- Earning Date
- VIVK 11-18-2025
- GOVX 11-11-2025
- Dividend Yield
- VIVK N/A
- GOVX N/A
- EPS Growth
- VIVK N/A
- GOVX N/A
- EPS
- VIVK N/A
- GOVX N/A
- Revenue
- VIVK $124,048,464.00
- GOVX $6,143,044.00
- Revenue This Year
- VIVK N/A
- GOVX N/A
- Revenue Next Year
- VIVK N/A
- GOVX N/A
- P/E Ratio
- VIVK N/A
- GOVX N/A
- Revenue Growth
- VIVK 98.83
- GOVX 1943.07
- 52 Week Low
- VIVK $0.24
- GOVX $0.43
- 52 Week High
- VIVK $1.68
- GOVX $3.88
- Technical
- Relative Strength Index (RSI)
- VIVK 28.70
- GOVX 36.70
- Support Level
- VIVK $0.26
- GOVX $0.46
- Resistance Level
- VIVK $0.49
- GOVX $0.59
- Average True Range (ATR)
- VIVK 0.08
- GOVX 0.04
- MACD
- VIVK -0.01
- GOVX -0.01
- Stochastic Oscillator
- VIVK 2.61
- GOVX 36.64
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.